Related Experiment Video
Updated: Mar 30, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Prospects for the future of prostate cancer vaccines
Ravi A Madan1, James L Gulley1
1a Genitourinary Malignancies Branch , National Cancer Institute , Bethesda , MD , USA.
Abstract:
Cancer therapy is undergoing a revolution fueled by clinical data demonstrating that the immune system has significant anti-tumor capability. Although the main focus of this revolution currently rests upon immune checkpoint inhibitors in diseases such as melanoma, lung and bladder cancer, it was actually a therapeutic cancer vaccine in prostate cancer that provided the first data demonstrating that a modern immunotherapy, beyond cytokines, could enhance clinical outcomes. As immunotherapy is poised to take center stage among cancer therapies, the role of cancer vaccines remains somewhat undefined in prostate cancer, though emerging data suggest that vaccines could play a crucial therapeutic role.
Insights
Cancer vaccines, particularly in prostate cancer, are emerging as a key immunotherapy. Despite current focus on immune checkpoint inhibitors, vaccines show potential to enhance anti-tumor capabilities and clinical outcomes.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Cancer therapy is rapidly evolving with a focus on harnessing the immune system's anti-tumor potential.
- Immune checkpoint inhibitors are currently prominent, especially in melanoma, lung, and bladder cancers.
- Early successes in prostate cancer demonstrated that therapeutic cancer vaccines could improve outcomes.
Purpose of the Study:
- To evaluate the evolving role of cancer vaccines in prostate cancer therapy.
- To highlight the therapeutic potential of cancer vaccines within the broader field of immunotherapy.
- To underscore the significance of emerging data on vaccine efficacy.
Main Methods:
- Review of clinical data on cancer immunotherapy.
- Analysis of the impact of therapeutic cancer vaccines.
- Assessment of the current landscape of prostate cancer treatment.
Main Results:
- Clinical data confirm the immune system's significant anti-tumor capabilities.
- Therapeutic cancer vaccines in prostate cancer were pioneers in demonstrating immunotherapy's clinical benefits.
- Emerging data suggest a crucial therapeutic role for vaccines in prostate cancer.
Conclusions:
- Cancer vaccines are a vital component of immunotherapy, with significant potential in prostate cancer.
- While immune checkpoint inhibitors dominate current focus, vaccines offer a complementary or alternative strategy.
- Further research and clinical application of cancer vaccines are warranted for improved patient outcomes.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy

